Cargando...
A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
Asthma is a chronic respiratory condition that is characterized by reversible airflow obstruction. Interleukin-5 (IL-5) is involved in the pathophysiology of the disease and drugs targeting IL-5 have been studied for years as a possible treatment option for severe asthma. In this review, the authors...
Guardado en:
| Publicado en: | Cureus |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cureus
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223665/ https://ncbi.nlm.nih.gov/pubmed/30416896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3216 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|